Daniel Canos
Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA | Washington DC-Baltimore Area, United States
Daniel Canos’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA in April 2020 - Present
Deputy Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA in March 2019 - April 2020
Director, Evidence Development Division, Coverage and Analysis Group at Centers for Medicare & Medicaid Services in March 2018 - March 2019
University of North Carolina at Chapel Hill, Doctor of Philosophy (PhD)
St. X
The George Washington University, Master of Public Health (MPH), January 1999 to January 2001
The Food and Drug Administration is an agency within the Department of Health and Human Services. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors. FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. FDA also plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.
Discover more about FDAAidoc | Ex-FDA | Regulatory Expert AI/ML Medical Imaging SaMD
Director, Regulatory Affairs at Aidoc
(April 2025 – Present)
Ex-FDA | Consultant | Strategist | Dynamic Quality and Compliance Leader
President at R. Chase Consulting LLC
(April 2023 – Present)
Head of Global Regulatory Policy and Intelligence at Amgen
Adjunct Faculty at The George Washington University School of Medicine and Health Sciences
(December 2016 – Present)
Former FDA Acting Associate Commissioner for Minority Health and Deputy Office Director
Former FDA Acting Associate Commissioner for Minority Health and Deputy Office Director at FDA
(December 2023 – Present)
Clinical Analyst (Clinical Safety Review) at Office of New Drugs/CDER/US FDA
Co-Founder at NexTop-USA
(January 2011 – Present)
Regulatory CMC | Cell & Gene Therapy
Gene Therapy CMC Reviewer at FDA
(November 2023 – Present)
What is Daniel Canos email address?
Email Daniel Canos at [email protected] and [email protected]. This email is the most updated Daniel Canos's email found in 2026.
What is Daniel Canos phone number?
Daniel Canos phone number is 301-796-6057.
How to contact Daniel Canos?
To contact Daniel Canos send an email to [email protected] or [email protected]. If you want to call Daniel Canos try calling on 301-796-6057.
What company does Daniel Canos work for?
Daniel Canos works for FDA.
What is Daniel Canos's role at FDA?
Daniel Canos is Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH
What industry does Daniel Canos work in?
Daniel Canos works in the Government Administration industry.